Multiple sclerosis and fracture

References

• Moreira MA, Tilbery CP, Lana-Peixoto MA, Aspectos históricos de la esclerosis múltiple. Rev Neurol 2002;34: 378–83.
   Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221–31.
   PubMed Web of Science ®Google Scholar
• Dua T, Romani P. Atlas multiple sclerosis resources in the World 2008. Available from: http://www.who.int/mental_health/ neurology/Atlas_MS_WEB.pdf [last accessed 26 Nov 2010].
   Google Scholar
• Stenager E, Jensen K. Fracture in multiple sclerosis. Acta Neurol Belg 1991;91(5):296–302.
   Google Scholar
• Troiano RA, Jotkowitz A, Cook SD, Rate and types of fracture in corticosteroid-treated multiple sclerosis patients. Neurology 1992;42:1389–91.
   Google Scholar
• Logan WC Jr, Sloane R, Lyles KW, Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury. Arch Phys Med Rehabil 2008;89(2):237–43.
   PubMed Web of Science ®Google Scholar
• Bazelier MT, Van Staa TP, Uitdehaag BM, The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res 2011;26:2271.
   PubMed Web of Science ®Google Scholar
• Gibson JC, Summers GD. Bone health in multiple sclerosis. Osteoporos Int 2011;22:2935–49.
   PubMed Web of Science ®Google Scholar
• Nilsagård Y, Lundholm C, Denison E, Gunnarsson LG. Predicting accidental falls in people with multiple sclerosis: a longitudinal study. Clin Rehabil 2009;23:259–69.
   PubMed Web of Science ®Google Scholar
• Sibley WA, Bamford CR, Clark K, A prospective study of physical trauma and multiple sclerosis. J Neurol Neurosurg Psychiatry 1991;54:584–9.
   Google Scholar
• NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis, diagnosis and therapy. JAMA 2001;285:785–95.
   PubMed Web of Science ®Google Scholar
• Terzi T, Terzi M, Tander B, Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables. J Clin Neurosci 2010;17:1260–4.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Oden A, A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19(6):893–9.
   Google Scholar
• Marrie RA, Cutter G, Tyry T, Vollmer T. A cross-sectional study of bone health in multiple sclerosis. Neurology 2009;73:1394–8.
   PubMedGoogle Scholar
• Cosman F, Nieves J, Komar L, Fracture history and bone loss in patients with MS. Neurology 1998;51(4):1161–5.
   PubMed Web of Science ®Google Scholar
• Bazelier MT, Van Staa TP, Uitdehaag BM, Risk of fracture in patients with multiple sclerosis: a population-based cohort study. Neurology 2012;78:1967–73.
   PubMed Web of Science ®Google Scholar
• Bazelier MT, Bentzen J, Vestergaard P, The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers. Mult Scler 2012;18(11):1609–16.
   Google Scholar
• Ramagopalan SV, Seminog O, Goldacre R, Goldacre MJ. Risk of fracture in patients with multiple sclerosis: record-linkage study. BMC Neurology 2012;12:135.
   Google Scholar
• Dennison EM, Compston JE, Flahive J, Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 2012;50:1288–93.
   PubMed Web of Science ®Google Scholar
• Moen SM, Celius EG, Sandvik L, Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome. Neurology 2011;77:151–7.
   PubMed Web of Science ®Google Scholar
• Moen SM, Celius EG, Nordsletten L, Holmøy T. Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis. Acta Neurol Scand Suppl 2011;191:79–82.
   Google Scholar
• Weinstock-Guttman B, Gallagher E, Baier M, Risk of bone loss in men with multiple sclerosis. Mult Scler 2004;10: 170–5.
   PubMed Web of Science ®Google Scholar
• Zorzon M, Zivadinov R, Locatelli L, Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol 2005;12:550–6.
   PubMed Web of Science ®Google Scholar
• Dobson R, Ramagopalan1 S, Giovannoni G. Bone health and multiple sclerosis. Mult Scler J 2012;18(11):1522–8.
   PubMed Web of Science ®Google Scholar
• Gibson JC, Summers GD. Bone health in multiple sclerosis. Osteoporos Int 2011;22:2935–49.
   PubMed Web of Science ®Google Scholar
• Epstein AM, Inzerillo J, Caminis M, Zaidi. Disorders associated with acute rapid and severe bone loss. J Bone Miner Res 2003;18(12):2083–94.
   PubMed Web of Science ®Google Scholar
• Moen SM, Celius EG, Sandvik L, Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study. PLoS One 2012;7(9):e45703.
   PubMed Web of Science ®Google Scholar
• Sioka C, Papakonstantinou S, Fotopoulos A, Bone mineral density in ambulatory patients with multiple sclerosis. Neurol Sci 2011;32:819–24.
   PubMed Web of Science ®Google Scholar
• Weinstein RS. Glucocorticoid-induced osteoporosis. Rev Endocr Metab Disord 2001;2:65–73.
   PubMedGoogle Scholar
• Stepan JJ, Havrdova E, Tyblova M, Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clin Chim Acta 2004;348:147–54.
   Google Scholar
• Schwid SR, Goodman AD, Puzas JE, Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol 1996;53:753–7.
   PubMed Web of Science ®Google Scholar
• Shiek Ahmad B, Hill KD, O'Brien TJ, Falls and fracture in patients chronically treated with antiepileptic drugs. Neurology 2012;79:145–51.
   PubMed Web of Science ®Google Scholar
• Verdel BM, Souverein PC, Egberts TCG, Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fracture. Bone 2010;47(3):604–9.
   PubMed Web of Science ®Google Scholar
• Yuan FL, Li X, Lu WG, Regulatory T cells as a potent target for controlling bone loss. Biochem Bioph Res Co 2010;402(2):173–6.
   Google Scholar
• Polman CH, Reingold SC, Banwell B, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302.
   PubMed Web of Science ®Google Scholar
• Peterson EW, Cho CC, Von KL, Finlayson ML. Injurious falls among middle aged and older adults with multiple sclerosis. Arch Phys Med Rehabil 2008;89:1031–7.
   PubMed Web of Science ®Google Scholar
• Finlayson ML, Peterson EW, Cho CC. Risk factors for falling among people aged 45 to 90 years with multiple sclerosis. Arch Phys Med Rehabil 2006;87:1274–9.
   PubMed Web of Science ®Google Scholar
• Nilsagard Y, Lundholm C, Denison E, Gunnarsson LG. Predicting accidental falls in people with multiple sclerosis-a longitudinal study. Clin Rehabil 2009;23:259–69.
   PubMed Web of Science ®Google Scholar
• Matsuda PN, Shumway-Cook A, Ciol MA, Understanding falls in multiple sclerosis: association of mobility status, concerns about falling, and accumulated impairments. Phys Ther 2012;92:407–15.
   PubMed Web of Science ®Google Scholar
• Matsuda PN, Shumway-Cook A, Bamer AM, Falls in multiple sclerosis: incidence, causes, risk factors and health care provider response. PMR 2011;3:624–32.
   PubMedGoogle Scholar
• Kanis JA, Johnell O, Oden A, FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385–97.
   PubMed Web of Science ®Google Scholar
• Bazelier MT, van Staa TP, Uitdehaag BM, A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis. Neurology 2012;79(9):922–8.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. Bone health and osteoporosis: a report of the surgeon general. US Department of Health and Human Services, Rockville; 2004.
   Google Scholar
• Heinonen A, Kannus P, Sievanen H, Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 1996;348: 1343–7.
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Grey AB, Gamble GD, Reid IR. Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocr Metab 2010;95(3):1174–81.
   Google Scholar
• Center JR, Bliuc D, Nguyen ND, Osteoporosis medication and reduced mortality risk in elderly women and men. J Clin Endocr Metab 2011;96(4):1006–14.
   Google Scholar
• Sale JE, Beaton D, Posen J, Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 2011;22:2067–82.
   PubMed Web of Science ®Google Scholar
• Kampman MT, Eriksen EF, Holmøy T. Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications? Acta Neurol Scand Suppl 2011;191:44–9.
   Google Scholar
• Steffensen LH, Jørgensen L, Straume B, Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol 2011;258(9): 1624–31.
   Google Scholar
• Gillespie WJ, Gillespie LD, Parker MJ. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 2010;10:CD001255.
   Google Scholar